News Column

SAREPTA THERAPEUTICS, INC. FILES (8-K) Disclosing Results of Operations and Financial Condition, Financial Statements and Exhibits

August 7, 2014



Item 2.02 Results of Operations and Financial Condition.

On August 7, 2014, Sarepta Therapeutics, Inc. (the "Company") announced via press release the Company's results for the three months and six months ended June 30, 2014. A copy of the Company's press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this report furnished pursuant to Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references the information furnished pursuant to Item 2.02 of this report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. Exhibit Number Description 99.1 Earnings press release dated August 7, 2014.



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters